Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Forst

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Diabetes, Obesity & Metabolism|July 29, 2024
The role of incretin receptor agonists in the treatment of obesityThomas Forst, Christophe De Block, Stefano Del Prato, et al.
Nitric Oxide : Biology and Chemistry|November 19, 2003
Stimulation of endothelial nitric oxide synthase by proinsulin C-peptideThomas Wallerath, Thomas Kunt, Thomas Forst, et al.
Lancet (London, England)|November 13, 2012
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label studyJohn B Buse, Michael Nauck, Thomas Forst, et al.
Carbohydrate Research|April 28, 2009
Physicochemical features of ultra-high viscosity alginatesHenning Storz, Kilian J Müller, Friederike Ehrhart, et al.
Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cardiovascular Diabetology|March 20, 2024
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, et al.
Cardiovascular Diabetology|May 2, 2025
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Jaime Almandoz, Lisa Anderson, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Diabetes, Obesity & Metabolism|July 29, 2024
The role of incretin receptor agonists in the treatment of obesityThomas Forst, Christophe De Block, Stefano Del Prato, et al.
Nitric Oxide : Biology and Chemistry|November 19, 2003
Stimulation of endothelial nitric oxide synthase by proinsulin C-peptideThomas Wallerath, Thomas Kunt, Thomas Forst, et al.
Lancet (London, England)|November 13, 2012
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label studyJohn B Buse, Michael Nauck, Thomas Forst, et al.
Carbohydrate Research|April 28, 2009
Physicochemical features of ultra-high viscosity alginatesHenning Storz, Kilian J Müller, Friederike Ehrhart, et al.
Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cardiovascular Diabetology|March 17, 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cardiovascular Diabetology|March 20, 2024
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, et al.
Cardiovascular Diabetology|May 2, 2025
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomesOliver Schnell, Jaime Almandoz, Lisa Anderson, et al.
Pageof 15